Help Centre

CSL's Naylor to head flu vaccine unit

CSL's CFO Gordon Naylor's role as head of its influenza vaccines business may set him up to take over from CEO Paul Perreault – eventually.

Typically the only new role of interest to a company’s chief financial officer would be the chief executive role, so it’s interesting to see CSL’s (ASX: CSL) CFO Gordon Naylor hanging up his calculator to head up the company’s new global influenza vaccine business.

IMPORTANT: This information has been prepared without taking into account your objectives, financial situation or needs and you should consider if the information is appropriate for you before making an investment decision. Unless otherwise specifically stated or disclosed (such as the InvestSMART Diversified Portfolios Product Disclosure Statement), neither InvestSMART Financial Services Pty Ltd nor any of its Related Companies make any recommendations as to the merits of any investment opportunity referred to in its emails or its related websites. Product disclosure statements for financial products offered through InvestSMART can be downloaded from this website or obtained by contacting 1300 880 160. You should consider the product disclosure statement before making a decision about the product. All indications of performance returns are historical and can not be relied upon as an indicator for future performance.